Bigul

Bharat Parenterals Ltd - 541096 - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2

Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company Bharat Parenterals Ltd 2 CIN NO. L24231GJ1992PLC018237 3 Report filed for FY 2023-2024 Details of the Current block (all figures in Rs crore): 4 2 - year block period (Specify financial years)* 2022-23, 23-24 5 Incremental borrowing done in FY (T)(a) 0.00 6 Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) 0.00 7 Actual borrowing done through debt securities in FY (T)(c) 0.00 8 Shortfall in the borrowing through debt securities, if any, for FY (T - 1) carried forward to FY (T) (d) 0 8Quantum of (d), which has been met from (c)(e)* 0 9 Shortfall, if any, in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative, write 'nil'}* 0 Details of penalty to be paid, if any, in respect to previous block (all figures in Rs crore): 2 - year Block period (Specify financial years)2021-2022 Amount of fine to be paid for the block, if applicable Fine = 0.2% of {(d) - (e)}#0.00 Name of the Company Secretary :-Krutika BhattbhattDesignation :-Company Secretary and Compliance officer Name of the Chief Financial Officer :- Jignesh Shah Designation : -Chief Financial Officer Date: 25/04/2024
25-04-2024
Bigul

Bharat Parenterals Ltd - 541096 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyBharat Parenterals Ltd 2CIN NO.L24231GJ1992PLC018237 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 71779888.00 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Krutika Bhattbhatt Designation: Company Secrtary and Compliance officer EmailId: [email protected] Name of the Chief Financial Officer: Jignesh Shah Designation: Chief Financial Officer EmailId: [email protected] Date: 25/04/2024 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
25-04-2024
Bigul

Bharat Parenterals Ltd - 541096 - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 (1) (D) Of SEBI LODR Provision For Preferential Allotment Of Equity Shares

Bharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/04/2024 ,inter alia, to consider and approve Intimation of Board Meeting under regulation 29 (1) (d) of SEBI LODR provision for Preferential Allotment of Equity Shares
25-04-2024
Bigul

Bharat Parenterals Ltd - 541096 - Compliances-Compliance Certificate For The Period Ended March, 2024.

Compliance Certificate for the year ended on 31st March, 2024 related to share transfer facility.
13-04-2024
Bigul

Bharat Parenterals Ltd - 541096 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Intimation under regulation 74(5) of SEBI(Depositories and Participants) Regulations, 2018 for period ended on 31st March, 2024.
13-04-2024
Bigul

Bharat Parenterals Ltd - 541096 - Closure of Trading Window

Intimation of Closure of Trading Window for Quarter ended on 31st March 2024 for declaration of Audited Financial Result for the Financial Year ended on 31st March, 2024.
30-03-2024
Bigul

Bharat Parenterals Ltd - 541096 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer

Additional Details required for corporate Announcement filed with SEBI for Announcement of Resignation of Company Secretary /Compliance officer filled as on 2nd October, 2023. For discrepancies in Announcement as Resignation Letter was missing in earlier announcement.
28-03-2024
Bigul

Bharat Parenterals Ltd - 541096 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation under regulation 39(3) for Issue of Duplicate Share certificates
28-03-2024
Bigul

Bharat Parenterals Ltd - 541096 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation under regulation 39 (3) - Loss of Share Certificates
22-03-2024
Next Page
Close

Let's Open Free Demat Account